A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis-Reference-Cited by-同舟云学术

A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis

Published:2024-07 Issue:1 Volume:106 Page:145-153
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Winkelmayer Wolfgang C.^ORCID,Lensing Anthonie W.A.,Thadhani Ravi I.,Mahaffey Kenneth W.,Walsh Michael^ORCID,Pap Ákos F.,Willmann Stefan,Thelen Kirstin,Hodge Sophie,Solms Alexander,Ingham Sheila J.M.,Eikelboom John

Funder

Bayer Pharma AG

McMaster University

Bayer

Bayer Fund

Publisher

Elsevier BV

Reference25 articles.

1. US Renal Data System 2020 annual data report: epidemiology of kidney disease in the United States;Johansen;Am J Kidney Dis,2021

2. Thrombosis and anticoagulation in the setting of renal or liver disease;Ribic;Hematology Am Soc Hematol Educ Program,2016

3. Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target;Eikelboom;Kidney int,2021

4. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

5. Factors XI and XII as targets for new anticoagulants;Weitz;Front Med (Lausanne),2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Catheter‐related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs;European Journal of Clinical Investigation;2024-09-12

2. Will Factor XI Inhibitors Replace Current Anticoagulants for Stroke Prevention in Atrial Fibrillation?;Current Cardiology Reports;2024-07-23

3. Factor XI inhibition in hemodialysis patients: the safer anticoagulation?;Kidney International;2024-07

4. Treatment strategies of the thromboembolic risk in kidney failure patients with atrial fibrillation;Nephrology Dialysis Transplantation;2024-05-30

5. Factor XI antagonists: the discovery of the philosopher's stone?;Clinical Kidney Journal;2024-04-22